ask="N/A"
ask_size="N/A"
average_daily_volume="117832"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.03"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-1.62"
change_From_52_week_low="0.23"
change_in_percent="-1.50%"
close="1.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.36"
ebitda="-8.62M"
eps_estimate_current_year="-0.31"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="13184000"
high="2.01"
high_52_weeks="3.59"
last_trade_date="3/8/2017"
last_trade_price="1.97"
last_trade_size="100"
last_trade_time="4:02pm"
low="1.95"
low_52_weeks="1.74"
market_capitalization="26.36M"
moving_average_200_day="2.27"
moving_average_50_day="1.96"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.00"
open="2.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.37%"
percent_change_from_50_day_moving_average="+0.55%"
percent_change_from_52_week_high="-45.13%"
percent_change_from_52_week_low="+13.22%"
previous_close="2.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.50"
price_per_sales="132.58"
revenue="201827.00"
shares_outstanding="13379000"
short_ratio="1.11"
stock_exchange="ASE"
symbol="CANF"
volume="36633"
weeks_range_52="1.74 - 3.59"
